These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 13044146)

  • 1. [Problems of blood coagulation. V. Effect of heparin-like anticoagulants on the first phase of blood coagulation].
    MARBET R; WINTERSTEIN A
    Helv Physiol Pharmacol Acta; 1952; 10(4):528-42. PubMed ID: 13044146
    [No Abstract]   [Full Text] [Related]  

  • 2. [Vasoactivity of anticoagulants].
    MATIS P; SCHEELE J
    Wien Klin Wochenschr; 1953 Jan; 65(5):102-3. PubMed ID: 13078266
    [No Abstract]   [Full Text] [Related]  

  • 3. A comparison of heparin and bishydroxycoumarin (dicumarol) as anticoagulants; resistance to tissue thromboplastin.
    BELKO JS; WARREN R
    AMA Arch Surg; 1957 Jan; 74(1):50-8. PubMed ID: 13381297
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of heparin and Bivalirudin on the kinetics of clot formation: Viscoelastic coagulation testing.
    Hasija S; Kapoor PM
    Ann Card Anaesth; 2017; 20(1):122. PubMed ID: 28074815
    [No Abstract]   [Full Text] [Related]  

  • 5. [Influence of nonachlazin, riboxin and isoptin on the blood coagulation system and the anticoagulant effect of heparin].
    Shevchenko LV; Ovchinnikova LK; Zolotukhin SI
    Farmakol Toksikol; 1980; 43(4):389-95. PubMed ID: 7439373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparative study of the effects of 4-chlorophenyl-2-hydroxy-4-oxo-2-butenoate and heparin on blood coagulation].
    Starkova AV; Sobin FB; Syropiatov BIa; Pulina NA
    Eksp Klin Farmakol; 2013; 76(10):25-6. PubMed ID: 24400385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heparin resistance.
    Anderson JA; Saenko EL
    Br J Anaesth; 2002 Apr; 88(4):467-9. PubMed ID: 12066718
    [No Abstract]   [Full Text] [Related]  

  • 8. Heparin is much more than just an anticoagulant.
    Day JR; Landis RC; Taylor KM
    J Cardiothorac Vasc Anesth; 2004 Feb; 18(1):93-100. PubMed ID: 14973810
    [No Abstract]   [Full Text] [Related]  

  • 9. [Changes in the adhesiveness of thrombocytes under the effect of anticoagulants].
    Merkulov MF; Lakin KM; Fel'dbaum VA; Efimov VS
    Farmakol Toksikol; 1968; 31(6):706-9. PubMed ID: 5713582
    [No Abstract]   [Full Text] [Related]  

  • 10. [Physiologic properties of heparin--thromboplastin complex].
    Kudriashov BA; Liapina LA
    Fiziol Zh SSSR Im I M Sechenova; 1978 Jun; 64(6):771-6. PubMed ID: 680264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selection for anticoagulant therapy in cardiac infarction using the heparin retarded coagulation time.
    PEEL AA
    Br Heart J; 1956 Jul; 18(3):378-84. PubMed ID: 13342301
    [No Abstract]   [Full Text] [Related]  

  • 12. Mechanism of the anticoagulant action of heparin.
    Björk I; Lindahl U
    Mol Cell Biochem; 1982 Oct; 48(3):161-82. PubMed ID: 6757715
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of fibrinolytic inhibitors and heparin on induced intravascular coagulation.
    Nordström S
    Acta Physiol Scand Suppl; 1970; 337():1-35. PubMed ID: 5311663
    [No Abstract]   [Full Text] [Related]  

  • 14. Heparin supplement counteracts the prohemostatic effect of prothrombin complex concentrate and factor IX concentrate: An in vitro evaluation.
    Brinkman HJ; Patiwael S; Tripathi S; Meijers JC
    Thromb Res; 2016 Mar; 139():102-10. PubMed ID: 26916304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The effects of various anticoagulants on blood coagulation: with special reference to false positive lupus anticoagulants].
    Onda H; Watanabe H
    Rinsho Byori; 1989 Dec; 37(12):1385-91. PubMed ID: 2515325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monitoring the effect of heparin bolus during percutaneous coronary angioplasty (PTCA): assessment of three bedside coagulation monitors.
    Hézard N; Metz D; Potron G; Nazeyrollas P; Maes D; Droulle C; Mulpas MC; Elaerts J; Nguyen P
    Thromb Haemost; 1998 Nov; 80(5):865-6. PubMed ID: 9843190
    [No Abstract]   [Full Text] [Related]  

  • 17. Mode of action of heparin and related drugs.
    Hemker HC; Beguin S
    Semin Thromb Hemost; 1991; 17 Suppl 1():29-34. PubMed ID: 1648791
    [No Abstract]   [Full Text] [Related]  

  • 18. Characterization of a new potent heparin. 7th communication: A comparative study of a new potent heparin in human after i.v. application.
    Bhargava AS; Wendt H; Günzel P
    Arzneimittelforschung; 1981; 31(2):386-8. PubMed ID: 7194658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Correlation between effects of heparin and hyaluronidase in blood coagulation].
    MYSLIVECEK J; VRKOCOVA M; JENICKOVA H
    Cas Lek Cesk; 1953 Jan; 92(5):126-31. PubMed ID: 13042866
    [No Abstract]   [Full Text] [Related]  

  • 20. [Anticoagulants (heparin, antivitamins K, principles and rules of use)].
    Lecompte T; Horellou MH
    Rev Prat; 1992 May; 42(10):1280-8. PubMed ID: 1609224
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.